Pfizer and Moderna COVID-19 Bivalent Vaccine Authorized for use in individuals aged Six Months to Five Years
In a December 8, 2022, announcement, the Food and Drug Administration (FDA) issued Emergency Use Authorization (EUA) for the use of Bivalent COVID-19 Vaccines from Pfizer BioN-Tech to be used as the third dose of the